Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma—What’s in a Name?
JAMA Dermatology · 2024
DOI: 10.1001/jamadermatol.2024.2817 ↗Kurz gefasst
Leserbrief in der Zeitschrift JAMA Dermatology, 2024. Verfasst von Elliot H Akama-Garren und 1 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Neoplasm Recurrence, Local, Cancer Survivors. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, CSRD VA, NIGMS NIH HHS.
Abstract (Originalsprache)
To the EditorMahama et al 1 administered a qualitative survey to assess the fear of cancer recurrence for 51 survivors of localized cutaneous melanoma.The authors found that despite good prognoses, approximately 75% of survivors had fear of cancer recurrence that was negatively associated with their psychological well-being, which, as noted by the authors, aligned with prior studies among patients with melanoma.Surprisingly, Mahama et al observed similar levels of clinical fear of cancer recurrence in patients with stage 0 and stage I to IIA localized cutaneous melanoma despite the fact that patients with stage 0 have a prognosis approaching 100% 5-year melanoma-specific survival.A systematic review 2 of 46 studies found that 82% of survivors of thyroid cancer scored 13 or higher on the Fear of Cancer Recurrence Inventory (FCRI), suggesting that patients with melanoma and thyroid cancer share high levels of cancer worry despite relatively high survival rates compared with other cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Harvard Medical School, Boston, Massachusetts.
- Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
- Department of Dermatology, VA Integrated Service Network 1, Jamaica Plain, Massachusetts.
Förderung
- NIAID NIH HHS
- CSRD VA
- NIGMS NIH HHS
Zitieren
APA
Akama-Garren, E. H., & Hartman, R. I. (2024). Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma—What’s in a Name?. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2024.2817
Vancouver
Akama-Garren EH, Hartman RI. Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma—What’s in a Name?. JAMA Dermatology. 2024. doi:10.1001/jamadermatol.2024.2817
BibTeX
@article{AkamaGarren2024,
author = {Akama-Garren, Elliot H and Hartman, Rebecca I},
title = {Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma—What’s in a Name?},
journal = {JAMA Dermatology},
year = {2024},
doi = {10.1001/jamadermatol.2024.2817}
}
EUVIMED